While RNA-medicine developer Wave Life Sciences Ltd. brought in a clinical data win, it also got knocked back a step as a major collaborator will go its separate way. That didn’t stop Wave’s stock ...
Novocure GmbH secured U.S. FDA approval for Optune Lua, a wearable device that delivers alternating electric fields or tumor treating fields that kill cancer cells. Indicated for use with PD-1/PD-L1 ...
Medic will use the money to accelerate the adoption of the company's breakthrough cancer biomarker discovery technology.
The agency based its decision on results from the Phase III ALINA trial in which Alecensa improved disease-free survival in ALK-positive NSCLC patients.
WEDNESDAY, Oct. 16, 2024 (HealthDay News) -- The U.S. Food and Drug Administration approved Itovebi (inavolisib), in ...
The babies were treated before symptom onset, and are sitting, standing, and walking independently, many consistent with ...
Sanofi is putting down $18 million across three historically Black medical schools as part of the French pharma's efforts to boost clinical trial diversity. | Big Pharma Sanofi is putting down $18 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback